Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Amendment to Performance Share Plan

14 Dec 2022 10:45

RNS Number : 6814J
DX (Group) PLC
14 December 2022
 

AIM: DX.

DX (Group) plc

("DX" or "the Group" or "the Company")

 

Company Performance Share Plan

 

DX, the provider of delivery solutions, including parcel freight, secure courier and logistics services, reports an amendment ("Amendment") to the Performance Condition of the Company's Performance Share Plan ("PSP"), which was established in December 2017 for directors and certain senior management of the Company ("Participants").

 

The Amendment introduces a further testing date of 21 December 2023, with the objective of retaining and fairly rewarding the 36 Participants, who are currently employed by the Group, in the PSP for a further year. The current third and final testing date for the PSP is on 21 December 2022 and the Amendment therefore extends the Performance Condition and adds a further measurement date in twelve months' time.

 

In light of the close proximity of the date of restoration of the Company's ordinary shares to trading on 19 October 2022 and the third testing date for the PSP under the plan on 21 December 2022, the Amendment creates additional time for the continued strong trading by the Group and its positive outlook to be recognised in a fair market price.

 

The Amendment also provides the further benefit of enabling DX to defer the implementation of a replacement Long Term Incentive Plan for a year and will help to retain and motivate the senior managers in the PSP.

 

A majority of shareholders of the Company's issued share capital, were consulted with respect to the Amendment.

 

Related party transaction

 

Under the AIM Rules for Companies, the Amendment to the PSP in relation to David Mulligan, Paul Ibbetson, Martin Illidge, Michael Sherry, and Kevin Galligan is classified as a Related Party Transaction. Accordingly, Mark Hammond, Mike Russell and Jon Kempster as Independent Directors consider, having consulted with finnCap, the Company's Nominated Adviser, that the terms of the Amendment are fair and reasonable insofar as its shareholders are concerned.

 

Enquiries:

DX (Group) plc

T: 020 3178 6378 (c/o KTZ

Jon Kempster, Senior Independent Non-executive Director

 Communications)

Mike Russell, Independent Non-executive Director

finnCap (Nominated Adviser & Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks (Corporate Finance)

Andrew Burdis/Charlotte Sutcliffe (ECM)

 

Liberum (Joint Broker to DX)

T: 020 3100 2000

Nick How/William Hall

 

 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis

Dan Mahoney

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANALFELAFEA
Date   Source Headline
28th Nov 202311:34 amRNSForm 8.5 (EPT/RI)
28th Nov 202310:52 amGNWForm 8.3 - [DX (Group) plc - 27 11 2023] - (CGAML)
27th Nov 20239:48 amRNSForm 8.5 (EPT/RI)
24th Nov 20239:53 amRNSForm 8.5 (EPT/RI)
23rd Nov 202312:47 pmRNSResult of AGM
23rd Nov 202311:06 amRNSForm 8.5 (EPT/RI)
23rd Nov 20239:07 amRNSForm 8.5 (EPT/RI) - DX (Group) Plc
23rd Nov 20237:00 amRNSAGM Statement
22nd Nov 202311:06 amRNSForm 8.5 (EPT/RI)
21st Nov 20233:00 pmRNSForm 8.3 - DX (Group) PLC
21st Nov 202310:55 amRNSForm 8.5 (EPT/RI)
21st Nov 20238:56 amRNSForm 8.5 (EPT/RI)
20th Nov 20239:55 amRNSForm 8.5 (EPT/RI)
17th Nov 20232:27 pmRNSForm 8.5 (EPT/RI)
17th Nov 202311:51 amRNSForm 8.5 (EPT/RI)
17th Nov 20239:51 amRNSForm 8.5 (EPT/RI)
17th Nov 20238:19 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
16th Nov 202311:47 amRNSForm 8.5 (EPT/RI)
16th Nov 20239:54 amRNSRecommended Cash Acquisition
15th Nov 202310:00 amRNSForm 8.5 (EPT/RI)
14th Nov 20232:24 pmRNSForm 8.3 - DX Group PLC
14th Nov 202310:00 amPRNForm 8.3 - DX (Group) plc
14th Nov 20239:56 amRNSForm 8.5 (EPT/RI)
13th Nov 202311:51 amRNSHolding(s) in Company
13th Nov 202311:00 amRNSForm 8.5 (EPT/RI)
13th Nov 20238:35 amRNSForm 8.5 (EPT/RI)
10th Nov 20233:25 pmGNWForm 8.3 - [DX (Group) plc - 09 11 2023] - (CGAML)
10th Nov 20239:42 amRNSForm 8.5 (EPT/RI)
9th Nov 20239:24 amRNSForm 8.5 (EPT/RI)
9th Nov 20238:41 amRNSForm 8.5 (EPT/RI)
8th Nov 202310:46 amRNSForm 8.5 (EPT/RI)
8th Nov 20238:51 amRNSForm 8.5 (EPT/RI)
7th Nov 202311:58 amRNSForm 8.5 (EPT/RI) - Replacement
7th Nov 202311:09 amRNSForm 8.5 (EPT/RI)
7th Nov 20238:32 amRNSForm 8.5 (EPT/RI)
6th Nov 202311:46 amRNSForm 8.3 - DX Group PLC
6th Nov 202310:46 amGNWForm 8.3 - [DX (GROUP) PLC - 03 11 2023] - (CGAML)
6th Nov 20239:30 amRNSForm 8.5 (EPT/RI)
6th Nov 20238:34 amRNSForm 8.5 (EPT/RI)
6th Nov 20237:00 amRNSAdditional Central Hub Opening in Nuneaton
6th Nov 20237:00 amRNSFurther Extension of PUSU Deadline
6th Nov 20237:00 amRNSPOSSIBLE OFFER FOR DX GROUP PLC
3rd Nov 20238:44 amRNSForm 8.5 (EPT/RI)
2nd Nov 202310:23 amRNSForm 8.5 (EPT/RI)
2nd Nov 20238:28 amRNSForm 8.5 (EPT/RI)
1st Nov 202310:22 amRNSForm 8.5 (EPT/RI)
1st Nov 20238:52 amRNSForm 8.5 (EPT/RI)
1st Nov 20237:00 amRNSPOSSIBLE OFFER FOR DX GROUP PLC
31st Oct 20238:56 amRNSForm 8.5 (EPT/RI)
31st Oct 20238:33 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.